1. Genetic polymorphisms in xenobiotic metabolism;Smith, C.A.D.; Smith, G.; Wolf, C.R.;Eur J Cancer,1994
2. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinsons disease;Smith, C.A.D.; Gough, A.C.; Leigh, P.N.;Lancet,1992
3. CYP2D6 genotyping and the association with lung cancer susceptibility;Wolf, C.R.; Smith, C.A.D.; Bishop, T.;Pharmacogenetics,1994
4. Lung cancer risk, occupational exposure and the debrosoquine metabolic phenotype;Caporaso, N.G.; Hayes, R.B.; Dosmeci, M.;Cancer Res,1989
5. Lung cancer and the debrisoquine metabolic phenotype;Caporaso, N.G.; Tucker, M.A.; Hoover, R.N.;J Natl Cancer Inst,1990